Transradial Technologies, Inc.

SYRACUSE, NY · Founded 2023 · Medtech · Private

Suction-based hemostasis device for radial artery closure

Claim this profile

Follows are private to you and power your alerts

Updated · transradialtechnologies.com

Sector
Medtech
Headquarters
SYRACUSE, NY
Founded
2023
Latest Form D
$350K, Nov 2024
Total capital
$350K
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$350K
1 Form D · last Nov 2024
23 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
2 pending

Capital timeline

2024FEDERAL ↑EQUITY ↓Cumulative $350K1st Form D$350K
2024FEDERAL ↑EQUITY ↓Cumulative $350K1st Form D$350K

Latest events

  • Private capital raisedForm D · SEC · 1st filing$350K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • Randolph Wayne HubbellExecutive Officer, DirectorNamed in SEC Form D filings
  • Ronald Paul CaputoExecutive Officer, DirectorNamed in SEC Form D filings
  • Stephen Michael GreenExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 2
  • PendingPositive Displacement Closure Devices And MethodsUSPTOApplication 19552863
  • PendingPositive Displacement Closure Devices And MethodsUSPTOApplication 19552788
  • Atlas5D, Inc.Similar federal contract value in Medtech · null in contracts
  • BLUE IRIS LABS, INC.Similar federal contract value in Medtech · null in contracts
  • Genomenon, Inc.Similar federal contract value in Medtech · null in contracts
  • Clear Scientific, LLCSimilar federal contract value in Medtech · null in contracts
  • AcQumen Medical, Inc.Similar federal contract value in Medtech · null in contracts
  • Covalon Technologies Ltd.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .